For instance, prostate cancer target antigen (PSMA) G3 CD28 and 4-1BB CAR-T cells had potent anti-tumor activity, including the induction of CAR-T cell-mediated tumor killing and ablation of PSMA-positive vessels in tumor sites [54]. This evidence concerns the gene FOLH1 and neoplasm.